For Investors

Press Releases

German National Health Insurance Agency Announces Addition of ReWalk 6.0 System to National Medical Device Directory

02/01/18

German GKV-Spitzenverband to Provide Exoskeleton Devices for all Qualifying Beneficiaries in Landmark National Policy Decision MARLBOROUGH, Mass. and BERLIN , Feb. 1, 2018 /PRNewswire/ -- GKV-Spitzenverband, the head office of German statutory health insurance (SHI), confirmed their decision to

Read More
Read More

ReWalk Robotics Ltd. Appoints Ori Gon as Chief Financial Officer

01/05/18

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Jan. 05, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq:RWLK) today announced the Company has appointed its Corporate Controller, Ori Gon as Chief Financial Officer (CFO), effective February 22, 2018 , succeeding Kevin

Read More
Read More

Correcting and Updating: ReWalk's Restore technology for stroke patients featured in MD&DI

11/30/17

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Nov. 30, 2017 /PRNewswire/ --  ReWalk Robotics' (Nasdaq: RWLK) ("ReWalk" or the "Company") innovative Restore soft exoskeleton system was featured in a recent story as one of the cutting edge technologies seeking to help stroke survivors heal and retain

Read More
Read More

ReWalk Robotics Announces Full Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares in Follow-on Public Offering

11/28/17

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Nov. 28, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ ReWalk ” or the “ Company ”) today announced that National Securities Corporation (“ National ”), the underwriter of ReWalk’s underwritten public offering of ordinary shares,

Read More
Read More

ReWalk Robotics Announces Pricing of Follow-on Public Offering of Ordinary Shares

11/17/17

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Nov. 17, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ ReWalk ” or the “ Company ”) today announced that it has priced its underwritten public offering of 6,857,000 ordinary shares at a price to the public of $1.05 per ordinary share.

Read More
Read More

ReWalk Robotics Reports Third Quarter 2017 Financial Results

11/02/17

-- 24% YOY growth in Q3 revenue to $1.7 million -- -- Coverage allowed by DGUV and Barmer in Germany of ReWalk personal devices -- YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Nov. 02, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or “the Company”) today announced its

Read More
Read More

German National Social Accident Insurance Agrees to Provide Personal Exoskeletons to Qualifying Beneficiaries

11/02/17

German social accident insurance association (DGUV) members have procured 20 ReWalk exoskeleton systems over time MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Nov. 2, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. ("ReWalk" or the "Company") (Nasdaq: RWLK) today announced that Germany's national social

Read More
Read More

ReWalk Robotics to Report Third Quarter 2017 Financial Results on November 2, 2017

10/26/17

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Oct. 26, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK), a leading manufacturer of exoskeleton systems, will release its third quarter 2017 financial results on Thursday, November 2, 2017 , before the U.S.

Read More
Read More

ReWalk Robotics Launches Public Offering of Ordinary Shares

10/17/17

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Oct. 17, 2017 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ ReWalk ” or the “ Company ”) today announced the commencement of its underwritten public offering of ordinary shares of the Company. All of the ordinary shares in the offering are

Read More
Read More

Soft Suit Exoskeleton Technology Begins Next Phase of Testing in Pre-Clinical Study

10/16/17

ReWalk Robotics & Harvard's Wyss Institute Are Collaborating on Design for Soft Exosuit for Stroke Survivors YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Oct. 16, 2017 /PRNewswire/ --  ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") today announced that the soft exosuit technology currently in

Read More
Read More

ReWalk Completes Critical Design Review Processes of Restore System for Move to Clinical Studies

10/16/17

Studies to focus on use with stroke patients MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Oct. 16, 2017 /PRNewswire/ -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk") announced today completion of all internal processes to initiate clinical studies and the initial production of its "soft suit"

Read More
Read More

Payer Coverage for ReWalk Expands in Germany with Barmer

09/14/17

Prominent German Insurer to Provide Exoskeleton Systems for All Qualifying Beneficiaries; Provides Update on U.S. Insurance Policy Coverage Reviews MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Sept. 14, 2017 /PRNewswire/ --  ReWalk Robotics Ltd. ("ReWalk" or the "Company") (Nasdaq: RWLK), today

Read More
Read More
Displaying 193 - 204 of 304